OUR STORY
Carmen's Biopharma is on a remarkable journey to redefine diabetes treatment using cannabinoids.
Inspired by the therapy that significantly helped Carmen, the founder's grandmother, we aim to make a real difference in the lives of diabetes patients. Our story is a testament to our dedication and passion for advancing medical solutions.
OUR TEAM
World-Class Leadership
Scientific, clinical, and financial expertise
Scientific Founder
Prof. Joseph Tam
Hebrew University; metabolic endocannabinoid expert; inventor of core CBD/CBG patent
Clinical Advisor
Dr. Lanzoni
Diabetes Research Institute,
University of Miami; leading
diabetes/metabolic clinician.
Clinical Operations
Precefi
Highly experienced Clinical Research team that has a Track records in bringing biotech startups to successful exits in +2B
CEO, Founder
Juan Romero
Experienced biopharma entrepreneur with ~$12M prior cannabinoid revenue
Investor
Michael Douglas
Academy Award-winning actor and producer; long-time advocate for health and wellness initiatives. Mr. Douglas is a very successful investor in the Pharmaceutical Industry. He got involved with Carmens because he believes in CBDs potential.
Investor
Rich Panico
Mr. Panico is an experienced biotech executive and co-founder/CEO of Symbio, which he grew into a leading U.S. and European CRO, supporting 70+ FDA and EMA approvals and a successful M&A exit.
Investor
John Lynch
Strategic investor supporting Carmen’s Biopharma mission.
Scaled ventures to
$1B+ with bold strategies.
Legal Counsel
Dale Hunt
Patent attorney with deep expertise in life sciences IP, patent strategy, and global commercialization, and previously was a partner at multiple national law firms.
Legal & Compliance
Hogal Lovells
Hogan Lovells is a leading global law firm with deep expertise in life sciences, providing legal and regulatory counsel across drug development, FDA strategy, IP, and complex cross-border matters.
OUR MISSION
Empowering Patients, Inspiring Change.
At Carmen's Biopharma, we are committed to redefining the way diabetes is treated. Our mission is to empower patients with innovative cannabinoid therapies that offer hope and healing. We believe in providing personalized care and leading the way in diabetes management.
OUR PROGRESS SO FAR
